Bespoke Extracts (BSPK) 10-Q 1 Jul 24 2024 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2024	Jul. 01, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Entity Information [Line Items]
Entity Registrant Name	BESPOKE EXTRACTS, INC.
Entity Central Index Key	0001409197
Entity File Number	000-52759
Entity Tax Identification Number	20-4743354
Entity Incorporation, State or Country Code	NV
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Contact Personnel [Line Items]
Entity Address, Address Line One	12001 E. 33rd Avenue
Entity Address, Address Line Two	Unit O
Entity Address, City or Town	Aurora
Entity Address, Country	CO
Entity Address, Postal Zip Code	80010
Entity Phone Fax Numbers [Line Items]
City Area Code	720
Local Phone Number	949-1143
Entity Listings [Line Items]
Title of 12(b) Security	None
No Trading Symbol Flag	true
Security Exchange Name	NONE
Entity Common Stock, Shares Outstanding		10,168,552

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current assets
Cash	$ 14,416	$ 6,607
Accounts receivable	43,125	45,226
Prepaid stock awards	6,104	9,206
Prepaid expense	1,250	5,000
Inventory, net	38,876	15,800
Total current assets	103,771	81,839
Furniture and equipment. Net	37,529	40,979
License	10,000	10,000
Right of Use Asset	192,536	209,542
Deposits	12,000	12,000
Total assets	355,836	354,360
Current liabilities
Accounts payable and accrued liabilities	1,137,298	961,255
Notes payable -- secured (net of discount of $14,693)	85,307
Operating lease liability	64,330	64,330
Total current liabilities	1,345,306	1,078,957
Note payable - related party	849,500	849,500
Long-Term Operating lease liability	133,652	150,460
Total liabilities	2,328,458	2,078,917
Commitments and contingencies (Note 10)
Stockholders’ Deficit
Preferred stock, value
Common stock, $0.001 par value: 3,000,000,000 authorized; 10,168,220 and 9,946,067 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	10,166	10,166
Common stock to issue 6,478 shares
Additional paid-in capital	23,697,971	23,631,918
Accumulated deficit	(25,680,759)	(25,366,641)
Total stockholders’ deficit	(1,972,622)	(1,724,557)
Total liabilities and stockholders’ deficit	355,836	354,360
Related Party
Current liabilities
Advances - related party	58,371	53,372
Series C Convertible Preferred Stock
Stockholders’ Deficit
Preferred stock, value

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Notes payable -- secured (Net of discount) (in Dollars)	$ 14,693	$ 14,693
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred Stock, shares authorized	50,000,000	50,000,000
Preferred stock, share issued	1	1
Preferred stock, share outstanding	1	1
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, share authorized	3,000,000,000	3,000,000,000
Common stock, shares issued	10,168,220	9,946,067
Common stock, shares outstanding	10,168,220	9,946,067
Common stock, shares issued	6,478	6,478
Series C Convertible Preferred Stock
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, share issued	1	1
Preferred stock, share outstanding	1	1
Preferred stock, designated share	1	1
Preferred stock, share stated value (in Dollars)	$ 24,000	$ 24,000

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Sales	$ 260,428	$ 89,016
Cost of products sold	157,847	78,667
Gross Profit	102,581	10,349
Operating expenses
Selling, general and administrative expenses	347,859	374,515
Professional fees	57,525	61,204
Consulting		18,000
Total operating expenses	405,384	453,719
Loss from operations	(302,803)	(443,370)
Other income / (expenses)
Interest (expense) / income	(11,315)	2,750
Total other (expense) / income	(11,315)	2,750
Loss before income tax	(314,118)	(440,620)
Provision for income tax
Net Loss	$ (314,118)	$ (440,620)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
Basic (in Shares)	10,168,220	10,107,108
NET LOSS PER COMMON SHARE OUTSTANDING
Basic (in Dollars per share)	$ (0.03)	$ (0.04)

Consolidated Statements of Op_2

Consolidated Statements of Operations (Parentheticals) - $ / shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Diluted	10,168,220	10,107,108
Diluted	$ (0.03)	$ (0.04)

Consolidated Statement of Stock

Consolidated Statement of Stockholders Deficit - USD ($)	Preferred Shares	Common Shares	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2022		$ 9,944	$ 23,201,758	$ (23,883,798)	$ (672,096)
Balance (in Shares) at Dec. 31, 2022	1	9,945,997
Purchase Wonderleaf		$ 222	49,778		50,000
Stock option expense			92,432		92,432
Net loss				(440,620)	(440,620)
Balance at Mar. 31, 2023		$ 10,166	23,343,968	(24,324,418)	(970,284)
Balance (in Shares) at Mar. 31, 2023	1	9,945,997
Balance at Dec. 31, 2023		$ 10,166	23,631,918	(25,366,641)	(1,724,557)
Balance (in Shares) at Dec. 31, 2023	1	10,168,220
Warrants issued with financing			15,635		15,635
Stock option expense			50,418		50,418
Net loss				(314,118)	(314,118)
Balance at Mar. 31, 2024		$ 10,166	$ 23,697,971	$ (25,680,759)	$ (1,972,622)
Balance (in Shares) at Mar. 31, 2024	1	10,168,220

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities
Net Loss	$ (314,118)	$ (440,620)
Adjustments to reconcile net loss to net cash used in operating activities
Inventory reserve		40,393
Depreciation	3,450	1,785
Amortization of right of use asset, net	17,006	16,348
Amortization expense for prepaid expenses for consulting shares	3,102	21,544
Amortization of debt discount	942
Stock based compensation and stock option expense	50,418	92,432
Changes in operating assets and liabilities:
Accounts receivable	2,101	(46,483)
Prepaid expenses	3,750	(19,170)
Inventory	(23,076)	(53,403)
Accounts payable and accrued liabilities	176,042	196,256
Operating lease liability, net	(16,808)	(16,150)
Net Cash (used in) operating activities	(97,191)	(207,068)
Cash flow from financing activities
Payment of inventory earnout		(90,000)
Proceeds from issuance of note payable - related party		277,000
Proceeds from advances - related party	5,000
Proceeds from secured notes payable	100,000
Net cash provided by financing activities	105,000	187,000
Net increase / (decrease) in cash	7,809	(20,068)
Cash at beginning of period	6,607	24,433
Cash at end of period	14,416	4,365
Supplemental disclosure of cash flow information
Cash paid for interest
Cash paid for income taxes
Noncash investing and financing activities:
Stock issued to Wonderleaf for fixed assets and license		50,000
Warrants issued for financing	$ 15,635

Nature of Operations, Significa

Nature of Operations, Significant Accounting Policies and Going Concern	3 Months Ended
	Mar. 31, 2024
Nature of Operations, Significant Accounting Policies and Going Concern [Abstract]
NATURE OF OPERATIONS, SIGNIFICANT ACCOUNTING POLICIES AND GOING CONCERN	1. NATURE OF OPERATIONS, SIGNIFICANT ACCOUNTING POLICIES AND GOING CONCERN Nature of Business Operations Bespoke Extracts, Inc. (the “Company”) is a Nevada corporation focused on operating in the regulated cannabis markets in the United States. Through Bespoke Extracts Colorado, LLC (“Bespoke Colorado”), we operate a marijuana infused products production facility in Aurora, Colorado. On December 2, 2021, Bespoke Colorado, a newly formed wholly-owned subsidiary of the Company entered into an asset purchase agreement with WonderLeaf, LLC (“WonderLeaf”), and on December 7, 2021, Bespoke Colorado and WonderLeaf entered into an amendment to such asset purchase agreement (as amended, the “WonderLeaf Purchase Agreement”). On January 3, 2023, the Company completed the acquisition of the WonderLeaf assets and the change of control was approved by the Colorado Marijuana Enforcement Division for 222,223 shares of common stock valued at $50,000, or $0.225 per share. At the time of acquisition Wonderleaf had no operations or no employees and was not considered a business. Principles of Consolidation The accompanying condensed consolidated unaudited financial statements include the accounts of Bespoke Extracts, Inc., and its wholly owned subsidiary Bespoke Extracts Colorado, LLC. All inter-company balances have been eliminated. Going Concern The accompanying consolidated financial statements have been prepared assuming a continuation of the Company as a going concern. The Company had negative cash flows from operations of $97,191 for the three months ended March 31, 2024, and a working capital deficit of $1,241,535 and accumulated deficit of $25,680,759, as of March 31, 2024. This raises substantial doubt about our ability to continue as a going concern for a period of one year from the date of these financial statements. The Company’s ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. There is no assurance that this series of events will be satisfactorily completed. Further, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. If additional financing is not available or is not available on acceptable terms, we will have to curtail or cease our operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence. These financial statements do not include any adjustments that might arise from this uncertainty. Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the accompanying consolidated financial statements and accompanying notes. Significant estimates include the assumption used in the valuation of equity-based transactions, valuation of intangible assets, allowance for provision for credit losses and inventory valuation and reserves. Actual results could differ from those estimates. Cash and Cash Equivalents Cash and cash equivalents include all highly liquid investments with original maturities of three months or less at the time of purchase. At March 31, 2024 and December 31, 2023, the Company did not have any cash equivalents. The Company did not have any cash in excess of FDIC limits of $250,000 at any single bank. Fair Value of Financial Instruments The carrying amounts of cash, accounts receivable, inventory, fixed assets, licenses, and other assets, accounts payable, accrued liabilities, and notes payable approximate their fair values as of March 31, 2024 and December 31, 2023, respectively, because of their short-term natures and the Company’s borrowing rate of interest. Accounts Receivable Accounts receivable are recorded at fair value on the date revenue is recognized. The Company provides allowances for provision for credit losses for estimated losses resulting from the inability of its customers to repay their obligation. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to repay, additional allowances may be required. The Company provides for potential uncollectible accounts receivable based on specific customer identification and historical collection experience adjusted for existing market conditions. If market conditions decline, actual collection experience may not meet expectations and may result in decreased cash flows and increased provision for credit losses. The policy for determining past due status is based on the contractual payment terms of each customer, which are generally net 14 or net 30 days. Once collection efforts by the Company are exhausted, the determination for charging off uncollectible receivables is made. At March 31, 2024 and December 31, 2023, the Company has recorded an allowance for doubtful accounts of $0 and $0, respectively. Inventory, net Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out basis and net realizable value. Net realizable value is defined as sales price less cost of completion, disposition and transportation and a normal profit margin. As of March 31, 2024 and December 31, 2023, inventory amounted to $38,876, and $15,800 net of reserves, respectively, which consisted of finished goods of $0 and $0. Property and equipment Property and equipment is recorded at cost and capitalized from the initial date of service. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When property and equipment is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation is provided over the estimated useful lives of the related assets using the straight-line method for financial statement purposes. The Company uses other depreciation methods (generally accelerated) for tax purposes where appropriate. The estimated useful lives for significant property and equipment categories are as follows: Schedule of Estimated useful Lives of Property and Equipment Furniture and Equipment 5 years License License represents the Colorado license for distributing cannabis. Revenue Recognition We account for revenue in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standard Codification Topic 606, “Revenue from Contracts with Customers”. Revenue is measured based on the amount of consideration that we expect to receive, reduced by discounts and estimates for credits and returns (calculated based upon previous experience and management’s evaluation). Outbound shipping charged to customers is recognized at the time the related merchandise revenues are recognized and are included in net revenues. Inbound and outbound shipping and delivery costs are included in cost of revenues. Our products are sold directly to licensed marijuana dispensaries in Colorado. Revenue is recognized when control of the merchandise is transferred to the customer, which generally occurs upon shipment. Payment is typically due on the date of shipment or within 14 to 30 days. As of March 31, 2024 one customer accounted for approximately 42% of the total accounts receivable. As of December 31, 2023, two customers amounted to 19.4% and 14.9% of accounts receivable. Stock Based Compensation Stock options and warrants issued to consultants and other non-employees as compensation for services provided to the Company are accounted for based on the fair value of the services provided or the estimated fair market value of the option or warrant, whichever is more reliably measurable, and in accordance with FASB ASC 718 , Compensation-Stock Compensation, Net Income / (Loss) per Share Basic income / (loss) per share amounts are computed based on net income / (loss) divided by the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if potentially dilutive securities were exercised or converted to common stock. The dilutive effect of options and warrants and their equivalent is computed by application of the treasury stock method and the effect of convertible securities by the “if converted” method. The effect of 129,876 warrants and 1,570,341 options is anti-dilutive for the three months ended March 31, 2024 as they are not in the money. Recent accounting pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other standard setting bodies that are adopted by the Company as of the specified effective date. The Company did not adopt any new accounting pronouncements in the reporting period ended March 31, 2024. Income Taxes We utilize the asset and liability method of accounting for income taxes. We recognize deferred tax liabilities or assets for the expected future tax consequences of temporary differences between the book and tax basis of assets and liabilities. We regularly assess the likelihood that our deferred tax assets will be recovered from future taxable income. We consider projected future taxable income and ongoing tax planning strategies in assessing the amount of the valuation allowance necessary to offset our deferred tax assets that will not be recoverable. We have recorded and continue to carry a full valuation allowance against our gross deferred tax assets that will not reverse against deferred tax liabilities within the scheduled reversal period. If we determine in the future that it is more likely than not that we will realize all or a portion of our deferred tax assets, we will adjust our valuation allowance in the period we make the determination. We expect to provide a full valuation allowance on our future tax benefits until we can sustain a level of profitability that demonstrates our ability to realize these assets.

Asset Purchase Agreement

Asset Purchase Agreement	3 Months Ended
	Mar. 31, 2024
Asset Purchase Agreement [Abstract]
ASSET PURCHASE AGREEMENT	2. ASSET PURCHASE AGREEMENT On January 3, 2023, the Company completed the acquisition of the WonderLeaf assets for 222,223 shares of common stock valued at $50,000, or $0.225 per share. At the time of acquisition WonderLeaf had no operations or no employees and was not considered a business. Pursuant to ASU 2017-01 and ASC 805, the Company analyzed the business of WonderLeaf to determine if the Company acquired a business or acquired assets. Based on this analysis, the Company determined that it acquired assets. No goodwill was recorded since the purchase was accounted for as an asset purchase. In accordance with ASC 805, the fair value of the assets acquired is based on either the fair value of the consideration given or the fair value of the assets acquired, whichever is more clearly evident, and thus, more reliably measurable. The Company used the market price of the 222,223 common shares issued of $50,000 as the fair value of the assets acquired since this value was more clearly evident, and thus, more reliably measurable than the fair value of the license and fixed assets acquired. Company management determined if the Company acquired a business or acquired assets. The FASB issued new guidance (ASU 2017-01) that changed the definition of a business to assist entities with evaluating when a set of transferred assets and activities is a business. The guidance requires an entity to evaluate if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets; if so, the set of transferred assets and activities is not a business. The guidance also requires a business to include at least one substantive process and narrows the definition of outputs by more closely aligning it with how outputs are described in ASC 606. Under the new guidance, an entity first determines whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If this threshold is met, the set is not a business. If it’s not met, the entity then evaluates whether the set meets the requirement that a business include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create outputs. Under the ASU, a set is not a business when substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. Pursuant to 805-10-55-83, the Company first considered the guidance in paragraphs 805-10-55-5A through 55-5C. The identifiable assets that could be recognized in the purchase only included the license and fixed assets. Accordingly, the transaction was not considered a business. The monetary value of the 222,223 shares is deemed by the Company to be $50,000 in accordance with Accounting Standards Codification (“ASC”) 805-50-30 “Business Combinations”, the Company determined that if the consideration paid is not in the form of cash, the measurement may be based on either (i) the cost which is measured based on the fair value of the consideration given or (ii) the fair value of the assets (or net assets) acquired, whichever is more clearly evident and thus more reliably measurable. No goodwill should be recorded since the WPA was accounting for as an asset purchase. The Company determined that the fair value of the common shares issued was a better indicator which is more reliably measurable. The Company assigned a value of $10,000 to the licenses and $40,000 to the fixed assets acquired.

Furniture and Equipment.

Furniture and Equipment.	3 Months Ended
	Mar. 31, 2024
Furniture and Equipment. [Abstract]
FURNITURE AND EQUIPMENT.	NOTE 3 – FURNITURE AND EQUIPMENT. Machinery and equipment consisted of the following at: Schedule of Machinery and Equipment March 31, December 31, Furniture and equipment $ 2,745 $ 2,745 Machinery and Equipment 47,202 47,202 Fixed assets, total 49,947 49,947 Total: accumulated depreciation (12,418 ) (9,968 ) Fixed assets, net $ 37,529 $ 40,979 Depreciation expense for the three months ended March 31, 2024 and 2023 were $3,450 and $1,785 respectively.

Note Payable _ Related Party

Note Payable – Related Party	3 Months Ended
	Mar. 31, 2024
Note Payable – Related Party [Abstract]
NOTE PAYABLE – RELATED PARTY	4. NOTE PAYABLE – RELATED PARTY During the year ended December 31, 2023, Infinity Management, LLC an affiliate of Michael Feinsod, the Company’s chief executive officer, loaned the Company an additional $469,954. On September 5, 2023 $849,500 of notes payable were converted into a 5.0% interest bearing note due June 30, 2025 (the “Infinity Note”). In addition, repayment of the Infinity Note will be due out of the proceeds of a new debt or equity capital raise with net proceeds of more than $2,000,000. As of March 31, 2024 and December 31, 2023 the amount owed Infinity Management, LLC is $907,872 and $902,872, respectively. During the year ended December 31, 2023 the Company received additional advances from Infinity Management, LLC. of $53,372. During the three months ended March 31, 2024 the Company received additional advances from Infinity Management, LLC. of $5,000.

Note Payable _ Secured

Note Payable – Secured	3 Months Ended
	Mar. 31, 2024
Note Payable - Secured [Abstract]
NOTE PAYABLE – SECURED	5. NOTE PAYABLE – SECURED On February 16, 2024, the Company entered into and closed securities purchase agreements with investors pursuant to which the Company issued and sold to the investors an aggregate of $100,000 in 15% Senior Secured Notes due February 15, 2025 (the “Notes”), and warrants to purchase an aggregate of 100,000 shares of common stock, for an aggregate purchase price of $100,000. The Notes are senior in terms of priority and liquidation to all other existing debt obligations of the Company. The warrants have a term of two years and an exercise price of $0.11. The options were valued at $15,636 using a Black-Scholes pricing model with the following assumptions: dividend yield of 0%, annual volatility of 105%, risk free interest rate of 4.64%, an expected life of 1 years. The Company utilized the Relative Fair Value to allocate the value of the warrants and recorded it as debt discount. March 31, Note amount $ 100,000 Debt discount (15,635 ) Amortization of debt discount 942 Notes payable, net $ 85,307

Leases

Leases	3 Months Ended
	Mar. 31, 2024
Leases [Abstract]
LEASES	6. LEASES In connection with the WonderLeaf Purchase Agreement, Bespoke Colorado entered into a lease agreement (the “Lease”) with WL Holdings, Ltd. (“WL Holdings”) in December 2021. Pursuant to the Lease, Bespoke Colorado will lease from WL Holdings certain commercial space in Aurora, Colorado, where WonderLeaf’s business has been located, commencing upon signing of the Lease and Wonderleaf Purchase Agreement, for a term of five years, which Bespoke Colorado will have an option to renew for an additional five years. Monthly rent under the Lease will start at $6,000. The Lease grants the Company an option to purchase the property for $600,000. The Company has not decided whether it will exercise either option. Supplemental balance sheet information related to leases was as follows: March 31, Operating Leases Classification 2024 Right-of-use assets Right of use assets $ 192,536 Current lease liabilities Current operating lease liabilities 64,330 Non-current lease liabilities Long-term operating lease liabilities 133,652 Total lease liabilities $ 197,982 Lease term and discount rate were as follows: March 31, 2024 Weighted average remaining lease term (years) 3.69 Weighted average discount rate 4 % The component of lease costs was as follows: March 31, 2024 Operating lease cost $ 19,098 Variable lease cost (1) 1,050 Total lease costs $ 20,148 (1) Variable lease cost primarily relates to common area maintenance, property taxes and insurance on leased real estate. March 31, 2024 Cash paid for operating lease liabilities $ - Maturities of lease liabilities were as follows as of December 31, 2023: Operating Leases 2024 $ 59,107 2025 79,380 2026 72,765 Total undiscounted lease payments 211,252 Less: Present value discount (13,270 ) Total Present value of lease liabilities $ 197,982

Equity

Equity	3 Months Ended
	Mar. 31, 2024
Equity [Abstract]
EQUITY	7. EQUITY Common Stock and Preferred Stock On December 5, 2022 the Company approved an amendment to its articles of incorporation to effect a 45-to-1 reverse split of our common stock effective January 13, 2023. All prior amounts equity amounts have been presented to reflect this reverse split. As of March 31, 2024 and 2023, the Company’s authorized capital stock consists of 3,000,000,000 shares of common stock, par value $0.001, and 50,000,000 shares of preferred stock, par value $0.001. 1,000 shares of preferred stock are designated as Series A Convertible Preferred Stock. No On January 3, 2023, the Company completed the acquisition of the WonderLeaf assets for 222,223 shares of common stock valued at $50,000, or $0.225 per share. On December 14, 2021, the board of directors of the Company adopted the Company’s 2021 Equity Incentive Plan (the “2021 Plan”), pursuant to which up to an aggregate of 6,666,667 shares of common stock are available for issuance. Awards under the plan may include options (including incentive stock options and non-qualified stock options), stock appreciation rights, restricted stock, restricted stock units, performance share awards, or other equity-based awards, each as defined under the 2021 Plan. Options awarded under the 2021 Plan are to have an exercise price of not less than 100% of the fair market value of the common stock on the grant date and a term of not more than ten years from the option grant date. Effective August 1, 2022, the Company issued an aggregate of 266,667 shares of common stock to employees and consultants for services, including 155,556 shares that vest immediately, 55,556 shares that vested one year from the grant date, and 55,556 shares that will vest two years from the grant date. During the year ended December 31, 2022 the Company recorded an expense $1,104,928. For the year ended December 31, 2023 the Company recorded an expense of $70,907, respectively. For the three months ended March 31, 2024 the Company recorded and expense of $3,102. As of March 31, 2024 and December 31, 2023 the Company had a prepaid stock award of $6,104 and $9,206. Warrants On February 16, 2024, the Company entered into and closed securities purchase agreements with investors pursuant to which the Company issued and sold to the investors an aggregate of $100,000 in 15% Senior Secured Notes due February 15, 2025 (the “Notes”), and warrants to purchase an aggregate of 100,000 shares of common stock, for an aggregate purchase price of $100,000. The Notes are senior in terms of priority and liquidation to all other existing debt obligations of the Company. The warrants have a term of two years and an exercise price of $0.11. The following table summarizes the warrant activities during the three months ended March 31, 2024: Number of Weighted- Weighted- Outstanding at December 31, 2023 29,876 25.24 1.21 Granted 324,000 .11 8.47 Canceled or expired - - - Outstanding at March 31, 2024 353,876 $ 1.00 7.61 years Exercisable at March 31, 2024 242,376 $ 1.00 7.61 years Intrinsic value at March 31, 2024 $ - Options On December 14, 2021, the Company entered into an employment agreement with Hunter Garth, wherein the Company granted to Mr. Garth, pursuant to the Company’s 2021 Equity Incentive Plan, ten-year options to purchase 333,333 shares of common stock at an exercise price of $2.70 (representing a 120% premium over the closing price of the common stock on December 13, 2021). One-third of the options will vest on each yearly anniversary of the date of grant. The options were valued at $450,000 using a Black-Scholes pricing model. During the three months ending March 31, 2024 and 2023 the Company recorded $12,318 and $30,811 respectively of expenses associated with the vesting of these stock options. (See notes 10 and 11). On December 14, 2021, the Company entered into an employment agreement with Michael Feinsod, wherein the Company granted to Mr. Feinsod, pursuant to the Company’s 2021 Equity Incentive Plan, ten-year options to purchase 666,667 shares of common stock at an exercise price of $2.70 (representing a 120% premium over the closing price of the common stock on December 13, 2021). One-third of the options will vest on each yearly anniversary of the date of grant. The options were valued at $900,000 using a Black-Scholes pricing model During the three months ended March 31, 2023 and 2022 the Company recorded $24,635 and $61,261, respectively of expenses associated with the vesting of these stock options. (See notes 10 and 11). On August 17, 2023, the Company issued to several employees options to purchase a total of 222,500 shares of common stock at an exercise price of $0.20. The options vest over a period of 12 months and have a term of 5 years. The options were valued at $44,306 using a Black-Scholes pricing model. During the three months ended March 31, 2024 the Company recorded $10,087 of expenses associated with the vesting of these stock options On January 8, 2024, the Company issued to an employee options to purchase a total of 222,500 shares of common stock at an exercise price of $0.20. The options vest 50% on January 15, 2024 and 50% over a period of 12 months and have a term of 10 years. The options were valued at $8,030 using a Black-Scholes pricing model. During the three months ended March 31, 2024 the Company recorded $1,065 of expenses associated with the vesting of these stock options On March 1, 2024, the Company issued to several employees options to purchase a total of 99,000 shares of common stock at an exercise price of $0.22. The options vest over a period of 12 months and have a term of 5 years. The options were valued at $44,306 using a Black-Scholes pricing model. During the three months ended March 31, 2024 the Company recorded $1,594 of expenses associated with the vesting of these stock options The following table summarizes the option activities during the three months ended March 31 2024: Number of Weighted- Weighted- Outstanding at December 31, 2023 1,246,341 $ 2.67 7.94 years Granted 99,000 $ 0.22 4.88 years Canceled or expired - - Exercised - - Outstanding at March 31, 2024 1,345,341 $ 2.08 7.11 years Exercisable at March 31, 2024 690,508 $ 2.19 7.70 years Intrinsic value at March 31, 2024 $ - The future expense as of March 31, 2024 is $143,723.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2024
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	8. RELATED PARTY TRANSACTIONS On December 14, 2021, the Company entered into an employment agreement with Hunter Garth. Pursuant to the employment agreement, Mr. Garth will serve as the Company’s president and will receive a base monthly salary of $8,000. The Company also granted to Mr. Garth, pursuant to the Company’s 2021 Equity Incentive Plan, 500,000 shares of restricted common stock, which vested one year from the date of grant, and ten-year options to purchase 333,333 shares of common stock at an exercise price of $2.70 (representing a 120% premium over the closing price of the common stock on December 13, 2021). One-third of the options will vest on each yearly anniversary of the date of grant. In the event that Mr. Garth is terminated without cause or resigns with good reason (each as defined in the employment agreement), he will be entitled to his monthly base salary for twelve months following such termination. On December 14, 2021, the Company entered into an employment agreement with Michael Feinsod, the Company’s chief executive officer and chairman. Pursuant to the employment agreement, Mr. Feinsod will continue to serve as the Company’s chief executive officer and chairman and will receive a base monthly salary of $10,000. The Company also granted to Mr. Feinsod, pursuant to the Company’s 2021 Equity Incentive Plan, 1,000,000 shares of restricted common stock, which vested one year from the date of grant, and ten-year options to purchase 666,667 shares of common stock at an exercise price of $2.70 (representing a 120% premium over the closing price of the common stock on December 13, 2021). One-third of the options will vest on each yearly anniversary of the date of grant. In the event that Mr. Feinsod is terminated without cause or resigns with good reason (each as defined in the employment agreement), he will be entitled to his monthly base salary for twelve months following such termination. During the year ended December 31, 2023, Michael Feinsod, the Company’s chief executive officer, loaned the Company an additional $487,372. As of March 31, 2024 and December 31, 2023 the amount owed Michael Feinsod is $907,872 and $902,872, respectively. All loans are payable upon demand. During the three months ended March 31, 2024 an additional $5,000 was advanced. On September 5, 2023 $849,500 of notes payable were converted into a 5% interest bearing note due June 30, 2025. The note contains provisions whereby it is intended to be subordinate to any senior secured debt the Company may incur while it is outstanding. In addition, repayment of the note will be due in full out of the proceeds of a new debtor equity capital raise with net proceeds of more than $2,000,000. (See Note 4.) As of March 31, 2024 Michael Feinsod is owed a total of $253,938 of accrued salary and accounts payable of $156,944.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	9. COMMITMENTS AND CONTINGENCIES In connection with a stock purchase agreement, on October 28, 2021, a convertible debenture with an original issue date of December 24, 2019, as amended by Amendment No. 1 thereto, dated May 28, 2020, Amendment No. 2 thereto, dated August 21, 2020, Amendment No. 3 thereto, dated December 10, 2020, Amendment No. 4 thereto, dated January 15, 2021, Amendment No. 5 thereto, dated April 2, 2021, and Amendment No. 6 thereto, dated August 2, 2021 (as amended, the “Debenture”) with an original principal amount of approximately $400,000 was terminated, and all amounts due and payable thereunder forgiven pursuant to a cancellation and satisfaction of debenture agreement entered into between the Company and the Debenture holder (the “Debt Cancellation Agreement”). In exchange for cancellation of the debt owed under the Debenture, the Company transferred to the holder certain domain names and agreed to pay the holder, beginning December 1, 2021, and on a monthly basis through August 31, 2022, 40% of the operating profit generated from sale of the existing CBD inventory of the Company (the “Inventory Earn Out”), and on August 31, 2022, to make a final payment equal to an amount of $75,000 minus the total of the monthly payments made under the Inventory Earn Out. The inventory earn-out agreement was amended on November 11, 2022 (see Note 3) such that the final payment under the inventory earn out was increased to $90,000 (less any payments previously made) and was due February 28, 2023. During the year ended December 31, 2023 the amount was paid. On December 14, 2021, the Company entered into an employment agreement with Hunter Garth. Pursuant to the employment agreement, Mr. Garth will serve as the Company’s president and will receive a base monthly salary of $8,000. The Company also granted to Mr. Garth, pursuant to the Company’s 2021 Equity Incentive Plan, 500,000 shares of restricted common stock, which vested one year from the date of grant, and ten-year options to purchase 333,333 shares of common stock at an exercise price of $2.70 (representing a 120% premium over the closing price of the common stock on December 13, 2021). One-third of the options will vest on each yearly anniversary of the date of grant. In the event that Mr. Garth is terminated without cause or resigns with good reason (each as defined in the employment agreement), he will be entitled to his monthly base salary for twelve months following such termination. On December 14, 2021, the Company entered into an employment agreement with Michael Feinsod, the Company’s chief executive officer and chairman. Pursuant to the employment agreement, Mr. Feinsod will continue to serve as the Company’s chief executive officer and chairman and will receive a base monthly salary of $10,000. The Company also granted to Mr. Feinsod, pursuant to the Company’s 2021 Equity Incentive Plan, 1,000,000 shares of restricted common stock, which vested one year from the date of grant, and ten-year options to purchase 666,667 shares of common stock at an exercise price of $0.06 (representing a 120% premium over the closing price of the common stock on December 13, 2021). One-third of the options will vest on each yearly anniversary of the date of grant. In the event that Mr. Feinsod is terminated without cause or resigns with good reason (each as defined in the employment agreement), he will be entitled to his monthly base salary for twelve months following such termination. On August 11, 2022, the Company and Bespoke Colorado entered into an asset purchase agreement with Osiris, LLC doing business as Best Day Ever (“BDE”) and Michael Gurtman. Pursuant to the purchase agreement, Bespoke Colorado agreed to purchase from BDE, and BDE agreed to sell to Bespoke Colorado, the assets of BDE, including certain licenses. The Company also agreed to assume certain leases, all as further set forth in the purchase agreement. As consideration for the acquisition of the assets, the Company agreed to issue 2,777,778 shares of common stock at the closing of the transaction. Closing of the purchase agreement was subject to receipt of certain governmental approvals and other customary closing conditions. The purchase agreement was terminated on November 18, 2022.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	10. SUBSEQUENT EVENTS Subsequent to March 31, 2024, Infinity Management, LLC, an affiliate of the Company’s chief executive officer, loaned the Company an additional $16,000. On May 20, 2024 the Company entered into and closed securities purchase agreements with investors pursuant to which the Company issued and sold to the investors an aggregate of $10,000 in 15% Senior Secured Notes due May 20, 2025 and warrants to purchase an aggregate of 10,000 shares of common stock, for an aggregate purchase price of $10,000. The Notes are senior in terms of priority and liquidation to all other existing debt obligations of the Company. The warrants have a term of two years and an exercise price of $0.11. On June 6, 2024 the Company entered into and closed securities purchase agreements with investors pursuant to which the Company issued and sold to the investors an aggregate of $25,000 in 15% Senior Secured Notes due June 6, 2025 and warrants to purchase an aggregate of 25,000 shares of common stock, for an aggregate purchase price of $25,000. The Notes are senior in terms of priority and liquidation to all other existing debt obligations of the Company. The warrants have a term of two years and an exercise price of $0.11.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (314,118)	$ (440,620)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	3 Months Ended
	Mar. 31, 2024
Nature of Operations, Significant Accounting Policies and Going Concern [Abstract]
Nature of Business Operations	Nature of Business Operations Bespoke Extracts, Inc. (the “Company”) is a Nevada corporation focused on operating in the regulated cannabis markets in the United States. Through Bespoke Extracts Colorado, LLC (“Bespoke Colorado”), we operate a marijuana infused products production facility in Aurora, Colorado. On December 2, 2021, Bespoke Colorado, a newly formed wholly-owned subsidiary of the Company entered into an asset purchase agreement with WonderLeaf, LLC (“WonderLeaf”), and on December 7, 2021, Bespoke Colorado and WonderLeaf entered into an amendment to such asset purchase agreement (as amended, the “WonderLeaf Purchase Agreement”). On January 3, 2023, the Company completed the acquisition of the WonderLeaf assets and the change of control was approved by the Colorado Marijuana Enforcement Division for 222,223 shares of common stock valued at $50,000, or $0.225 per share. At the time of acquisition Wonderleaf had no operations or no employees and was not considered a business.
Principles of Consolidation	Principles of Consolidation The accompanying condensed consolidated unaudited financial statements include the accounts of Bespoke Extracts, Inc., and its wholly owned subsidiary Bespoke Extracts Colorado, LLC. All inter-company balances have been eliminated.
Going Concern	Going Concern The accompanying consolidated financial statements have been prepared assuming a continuation of the Company as a going concern. The Company had negative cash flows from operations of $97,191 for the three months ended March 31, 2024, and a working capital deficit of $1,241,535 and accumulated deficit of $25,680,759, as of March 31, 2024. This raises substantial doubt about our ability to continue as a going concern for a period of one year from the date of these financial statements. The Company’s ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. There is no assurance that this series of events will be satisfactorily completed. Further, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. If additional financing is not available or is not available on acceptable terms, we will have to curtail or cease our operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence. These financial statements do not include any adjustments that might arise from this uncertainty.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the accompanying consolidated financial statements and accompanying notes. Significant estimates include the assumption used in the valuation of equity-based transactions, valuation of intangible assets, allowance for provision for credit losses and inventory valuation and reserves. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents include all highly liquid investments with original maturities of three months or less at the time of purchase. At March 31, 2024 and December 31, 2023, the Company did not have any cash equivalents. The Company did not have any cash in excess of FDIC limits of $250,000 at any single bank.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The carrying amounts of cash, accounts receivable, inventory, fixed assets, licenses, and other assets, accounts payable, accrued liabilities, and notes payable approximate their fair values as of March 31, 2024 and December 31, 2023, respectively, because of their short-term natures and the Company’s borrowing rate of interest.
Accounts Receivable	Accounts Receivable Accounts receivable are recorded at fair value on the date revenue is recognized. The Company provides allowances for provision for credit losses for estimated losses resulting from the inability of its customers to repay their obligation. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to repay, additional allowances may be required. The Company provides for potential uncollectible accounts receivable based on specific customer identification and historical collection experience adjusted for existing market conditions. If market conditions decline, actual collection experience may not meet expectations and may result in decreased cash flows and increased provision for credit losses. The policy for determining past due status is based on the contractual payment terms of each customer, which are generally net 14 or net 30 days. Once collection efforts by the Company are exhausted, the determination for charging off uncollectible receivables is made. At March 31, 2024 and December 31, 2023, the Company has recorded an allowance for doubtful accounts of $0 and $0, respectively.
Inventory, net	Inventory, net Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out basis and net realizable value. Net realizable value is defined as sales price less cost of completion, disposition and transportation and a normal profit margin. As of March 31, 2024 and December 31, 2023, inventory amounted to $38,876, and $15,800 net of reserves, respectively, which consisted of finished goods of $0 and $0.
Property and equipment	Property and equipment Property and equipment is recorded at cost and capitalized from the initial date of service. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When property and equipment is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation is provided over the estimated useful lives of the related assets using the straight-line method for financial statement purposes. The Company uses other depreciation methods (generally accelerated) for tax purposes where appropriate. The estimated useful lives for significant property and equipment categories are as follows: Schedule of Estimated useful Lives of Property and Equipment Furniture and Equipment 5 years
License	License License represents the Colorado license for distributing cannabis.
Revenue Recognition	Revenue Recognition We account for revenue in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standard Codification Topic 606, “Revenue from Contracts with Customers”. Revenue is measured based on the amount of consideration that we expect to receive, reduced by discounts and estimates for credits and returns (calculated based upon previous experience and management’s evaluation). Outbound shipping charged to customers is recognized at the time the related merchandise revenues are recognized and are included in net revenues. Inbound and outbound shipping and delivery costs are included in cost of revenues. Our products are sold directly to licensed marijuana dispensaries in Colorado. Revenue is recognized when control of the merchandise is transferred to the customer, which generally occurs upon shipment. Payment is typically due on the date of shipment or within 14 to 30 days. As of March 31, 2024 one customer accounted for approximately 42% of the total accounts receivable. As of December 31, 2023, two customers amounted to 19.4% and 14.9% of accounts receivable.
Stock Based Compensation	Stock Based Compensation Stock options and warrants issued to consultants and other non-employees as compensation for services provided to the Company are accounted for based on the fair value of the services provided or the estimated fair market value of the option or warrant, whichever is more reliably measurable, and in accordance with FASB ASC 718 , Compensation-Stock Compensation,
Net Income / (Loss) per Share	Net Income / (Loss) per Share Basic income / (loss) per share amounts are computed based on net income / (loss) divided by the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if potentially dilutive securities were exercised or converted to common stock. The dilutive effect of options and warrants and their equivalent is computed by application of the treasury stock method and the effect of convertible securities by the “if converted” method. The effect of 129,876 warrants and 1,570,341 options is anti-dilutive for the three months ended March 31, 2024 as they are not in the money.
Recent accounting pronouncements	Recent accounting pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other standard setting bodies that are adopted by the Company as of the specified effective date. The Company did not adopt any new accounting pronouncements in the reporting period ended March 31, 2024.
Income Taxes	Income Taxes We utilize the asset and liability method of accounting for income taxes. We recognize deferred tax liabilities or assets for the expected future tax consequences of temporary differences between the book and tax basis of assets and liabilities. We regularly assess the likelihood that our deferred tax assets will be recovered from future taxable income. We consider projected future taxable income and ongoing tax planning strategies in assessing the amount of the valuation allowance necessary to offset our deferred tax assets that will not be recoverable. We have recorded and continue to carry a full valuation allowance against our gross deferred tax assets that will not reverse against deferred tax liabilities within the scheduled reversal period. If we determine in the future that it is more likely than not that we will realize all or a portion of our deferred tax assets, we will adjust our valuation allowance in the period we make the determination. We expect to provide a full valuation allowance on our future tax benefits until we can sustain a level of profitability that demonstrates our ability to realize these assets.

Nature of Operations, Signifi_2

Nature of Operations, Significant Accounting Policies and Going Concern (Tables)	3 Months Ended
	Mar. 31, 2024
Nature of Operations, Significant Accounting Policies and Going Concern [Abstract]
Schedule of Estimated Useful Lives of Property and Equipment	The estimated useful lives for significant property and equipment categories are as follows: Furniture and Equipment 5 years

Furniture and Equipment. (Table

Furniture and Equipment. (Tables)	3 Months Ended
	Mar. 31, 2024
Furniture and Equipment. [Abstract]
Schedule of Machinery and Equipment	Machinery and equipment consisted of the following at: March 31, December 31, Furniture and equipment $ 2,745 $ 2,745 Machinery and Equipment 47,202 47,202 Fixed assets, total 49,947 49,947 Total: accumulated depreciation (12,418 ) (9,968 ) Fixed assets, net $ 37,529 $ 40,979

Note Payable _ Secured (Tables)

Note Payable – Secured (Tables)	3 Months Ended
	Mar. 31, 2024
Note Payable - Secured [Abstract]
Schedule of Relative Fair Value to Allocate the Value of Warrants and Debt Discount	The Company utilized the Relative Fair Value to allocate the value of the warrants and recorded it as debt discount. March 31, Note amount $ 100,000 Debt discount (15,635 ) Amortization of debt discount 942 Notes payable, net $ 85,307

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2024
Leases [Abstract]
Schedule of Supplemental Balance Sheet Information	Supplemental balance sheet information related to leases was as follows: March 31, Operating Leases Classification 2024 Right-of-use assets Right of use assets $ 192,536 Current lease liabilities Current operating lease liabilities 64,330 Non-current lease liabilities Long-term operating lease liabilities 133,652 Total lease liabilities $ 197,982
Schedule of Lease Term and Discount Rate	Lease term and discount rate were as follows: March 31, 2024 Weighted average remaining lease term (years) 3.69 Weighted average discount rate 4 %
Schedule of Lease Costs	The component of lease costs was as follows: March 31, 2024 Operating lease cost $ 19,098 Variable lease cost (1) 1,050 Total lease costs $ 20,148 (1) Variable lease cost primarily relates to common area maintenance, property taxes and insurance on leased real estate. March 31, 2024 Cash paid for operating lease liabilities $ -
Schedule of Maturities of Lease Liabilities	Maturities of lease liabilities were as follows as of December 31, 2023: Operating Leases 2024 $ 59,107 2025 79,380 2026 72,765 Total undiscounted lease payments 211,252 Less: Present value discount (13,270 ) Total Present value of lease liabilities $ 197,982

Equity (Tables)

Equity (Tables)	3 Months Ended
	Mar. 31, 2024
Equity [Abstract]
Schedule of Warrant Activities	The following table summarizes the warrant activities during the three months ended March 31, 2024: Number of Weighted- Weighted- Outstanding at December 31, 2023 29,876 25.24 1.21 Granted 324,000 .11 8.47 Canceled or expired - - - Outstanding at March 31, 2024 353,876 $ 1.00 7.61 years Exercisable at March 31, 2024 242,376 $ 1.00 7.61 years Intrinsic value at March 31, 2024 $ -
Schedule of Option Activities	The following table summarizes the option activities during the three months ended March 31 2024: Number of Weighted- Weighted- Outstanding at December 31, 2023 1,246,341 $ 2.67 7.94 years Granted 99,000 $ 0.22 4.88 years Canceled or expired - - Exercised - - Outstanding at March 31, 2024 1,345,341 $ 2.08 7.11 years Exercisable at March 31, 2024 690,508 $ 2.19 7.70 years Intrinsic value at March 31, 2024 $ -

Nature of Operations, Signifi_3

Nature of Operations, Significant Accounting Policies and Going Concern (Details)		3 Months Ended		12 Months Ended
	Jan. 03, 2023 USD ($) $ / shares shares	Mar. 31, 2024 USD ($) shares	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)
Nature of Operations, Significant Accounting Policies and Going Concern [Line Items]
Shares of common stock (in Shares) | shares	222,223
Common stock valued	$ 50,000
Common stock per share (in Dollars per share) | $ / shares	$ 0.225
Negative cash flows from operations		$ (97,191)	$ (207,068)
Working capital deficit		1,241,535
Accumulated deficit		(25,680,759)		$ (25,366,641)
FDIC limit		250,000
Allowance for doubtful accounts		0		0
Inventory net of reserves		38,876		15,800
Inventory finished goods		$ 0		$ 0
Warrant [Member]
Nature of Operations, Significant Accounting Policies and Going Concern [Line Items]
Option anti-dilutive shares (in Shares) | shares		129,876
Customer One [Member]
Nature of Operations, Significant Accounting Policies and Going Concern [Line Items]
Number of customer		1
Customer Two [Member]
Nature of Operations, Significant Accounting Policies and Going Concern [Line Items]
Number of customer				2
Customer Concentration Risk [Member] | Customer One [Member] | Accounts Receivable [Member]
Nature of Operations, Significant Accounting Policies and Going Concern [Line Items]
Risk percentage		42%		19.40%
Customer Concentration Risk [Member] | Customer Two [Member] | Accounts Receivable [Member]
Nature of Operations, Significant Accounting Policies and Going Concern [Line Items]
Risk percentage				14.90%
Equity Option [Member]
Nature of Operations, Significant Accounting Policies and Going Concern [Line Items]
Option anti-dilutive shares (in Shares) | shares		1,570,341

Nature of Operations, Signifi_4

Nature of Operations, Significant Accounting Policies and Going Concern (Details) - Schedule of Estimated Useful Lives of Property and Equipment	Mar. 31, 2024
Schedule of Estimated Useful Lives of Property and Equipment [Abstract]
Furniture and Equipment	5 years

Asset Purchase Agreement (Detai

Asset Purchase Agreement (Details) - USD ($)		3 Months Ended
	Jan. 03, 2023	Mar. 31, 2024
Asset Purchase Agreement Details [Abstract]
Licenses amount		$ 10,000
Fixed assets acquired		$ 40,000
WonderLeaf [Member]
Asset Purchase Agreement Details [Abstract]
Shares issued (in Shares)	222,223	222,223
Share value	$ 50,000	$ 50,000
Price per share (in Dollars per share)	$ 0.225
Consideration paid		$ 50,000
Common Stock [Member] | WonderLeaf [Member]
Asset Purchase Agreement Details [Abstract]
Shares issued (in Shares)		222,223
WonderLeaf [Member]
Asset Purchase Agreement Details [Abstract]
Acquisition date	Jan. 03, 2023

Furniture and Equipment. (Detai

Furniture and Equipment. (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Furniture and Equipment. [Abstract]
Depreciation expense	$ 3,450	$ 1,785

Furniture and Equipment. (Det_2

Furniture and Equipment. (Details) - Schedule of Machinery and Equipment - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Schedule of Machinery and Equipment [Line Items]
Fixed assets, total	$ 49,947	$ 49,947
Total: accumulated depreciation	(12,418)	(9,968)
Fixed assets, net	37,529	40,979
Furniture and equipment [Member]
Schedule of Machinery and Equipment [Line Items]
Fixed assets, total	2,745	2,745
Machinery and Equipment [Member]
Schedule of Machinery and Equipment [Line Items]
Fixed assets, total	$ 47,202	$ 47,202

Note Payable _ Related Party (D

Note Payable – Related Party (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Sep. 05, 2023
Note Payable – Related Party (Details) [Line Items]
Notes payable	$ 849,500	$ 849,500	$ 849,500
Percentage of interest bearing			5
Note Payable [Member]
Note Payable – Related Party (Details) [Line Items]
New debt	2,000,000		$ 2,000,000
Michael Feinsod [Member]
Note Payable – Related Party (Details) [Line Items]
Additional loan		469,954
Infinity Management, LLC [Member]
Note Payable – Related Party (Details) [Line Items]
Additional loan	5,000	53,372
Owned amount	$ 907,872	$ 902,872

Note Payable _ Secured (Details

Note Payable – Secured (Details) - USD ($)	Feb. 16, 2024	Mar. 31, 2024	Jan. 08, 2024
Note Payable Secured [Line Items]
Warrants term		2 years
Options vest valued (in Dollars)			$ 8,030
Dividend yield, percentage	0%
Annual volatility, percentage	105%
Risk free interest rate, percentage	4.64%
Expected life period	1 year
Warrant [Member]
Note Payable Secured [Line Items]
Investors issued aggregate value (in Dollars)	$ 100,000
Secured notes rate	15%
Shares of common stock (in Shares)	100,000
Warrant purchase price (in Dollars)	$ 100,000
Warrants term	2 years
Warrant exercise price (in Dollars per share)	$ 0.11
Options vest valued (in Dollars)	$ 15,636

Note Payable _ Secured (Detai_2

Note Payable – Secured (Details) - Schedule of Relative Fair Value to Allocate the Value of Warrants and Debt Discount - Warrant [Member]	3 Months Ended
	Mar. 31, 2024 USD ($)
Schedule of Relative Fair Value to Allocate the Value of Warrants and Debt Discount [Line Items]
Note amount	$ 100,000
Debt discount	(15,635)
Amortization of debt discount	942
Notes payable, net	$ 85,307

Leases (Details)

Leases (Details)	3 Months Ended
	Mar. 31, 2024 USD ($)
Leases (Details) [Line Items]
Rent amount	$ 6,000
Purchase of property	$ 600,000
Wonderleaf Purchase Agreement [Member]
Leases (Details) [Line Items]
Lease term	5 years
Renew for an additional term	5 years

Leases (Details) - Schedule of

Leases (Details) - Schedule of Supplemental Balance Sheet Information - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Schedule of Supplemental Balance Sheet Information [Line Items]
Right-of-use assets	$ 192,536	$ 209,542
Current lease liabilities	64,330	64,330
Non-current lease liabilities	133,652	150,460
Total lease liabilities	$ 197,982	$ 197,982

Leases (Details) - Schedule o_2

Leases (Details) - Schedule of Lease Term and Discount Rate	Mar. 31, 2024
2024
Weighted average remaining lease term (years)	3 years 8 months 8 days
Weighted average discount rate	4%

Leases (Details) - Schedule o_3

Leases (Details) - Schedule of Lease Costs	12 Months Ended
	Mar. 31, 2024 USD ($)
Schedule of Lease Costs [Abstract]
Operating lease cost	$ 19,098
Variable lease cost	1,050	[1]
Total lease costs	20,148
Cash paid for operating lease liabilities
[1] Variable lease cost primarily relates to common area maintenance, property taxes and insurance on leased real estate.

Leases (Details) - Schedule o_4

Leases (Details) - Schedule of Maturities of Lease Liabilities - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Schedule of Maturities of Lease Liabilities [Abstract]
2024		$ 59,107
2025		79,380
2026		72,765
Total undiscounted lease payments		211,252
Less: Present value discount		(13,270)
Total Present value of lease liabilities	$ 197,982	$ 197,982

Equity (Details)

Equity (Details) - USD ($)

3 Months Ended

12 Months Ended

Mar. 01, 2024

Feb. 16, 2024

Jan. 15, 2024

Jan. 08, 2024

Aug. 17, 2023

Jan. 03, 2023

Aug. 01, 2022

Dec. 14, 2021

Mar. 31, 2024

Mar. 31, 2023

Mar. 31, 2022

Dec. 31, 2023

Dec. 31, 2022

Dec. 13, 2021

Equity [Line Items]

Reverse stock split

45-to-1

Common stock, shares authorized

3,000,000,000

3,000,000,000

3,000,000,000

Common stock, par value (in Dollars per share)

$ 0.001

$ 0.001

$ 0.001

Preferred stock, shares authorized

50,000,000

50,000,000

50,000,000

Preferred stock, par value (in Dollars per share)

$ 0.001

$ 0.001

$ 0.001

Preferred stock, shares issued

1

1

Preferred stock, shares outstanding

1

1

Shares of common stock acquisition

222,223

Value of shares acquisitions (in Dollars)

$ 50,000

Common stock per share (in Dollars per share)

$ 0.225

Aggregate shares of common stock

266,667

Vest shares

155,556

Vesting period

5 years

5 years

Expenses (in Dollars)

$ 3,102

$ 70,907

Prepaid stock award (in Dollars)

$ 6,104

$ 9,206

Share issued and sold to investor (in Dollars)

$ 100,000

Share issued percentage

15%

Shares sold to investors

100,000

Warrant purchase price (in Dollars)

$ 50,000

Warrants term

2 years

Option to purchase share of common stock

99,000

222,500

222,500

Common stock exercise price (in Dollars per share)

$ 0.2

Options were valued (in Dollars)

$ 44,306

$ 900,000

Stock based compensation expenses (in Dollars)

1,065

Options vest

50 years

50 years

Options valued (in Dollars)

$ 8,030

Future expense (in Dollars)

$ 143,723

Warrant [Member]

Equity [Line Items]

Warrants term

2 years

Warrants exercise price (in Dollars per share)

$ 0.11

Options valued (in Dollars)

$ 15,636

Warrant [Member] | Senior Secured Note [Member]

Equity [Line Items]

Warrants exercise price (in Dollars per share)

$ 0.11

Vest One [Member]

Equity [Line Items]

Vest shares

55,556

Vesting period

1 year

Vest Two [Member]

Equity [Line Items]

Vest shares

55,556

Vesting period

2 years

Expenses (in Dollars)

$ 1,104,928

Common Stock [Member]

Equity [Line Items]

Warrant purchase price (in Dollars)

222

Common Stock [Member] | Mr. Garth [Member]

Equity [Line Items]

Options were valued (in Dollars)

$ 44,306

2021 Equity Incentive Plan [Member]

Equity [Line Items]

Sale of stock, number of shares issued

6,666,667

Fair market value of common stock, percentage

100%

Option grant date term

10 years

Common stock exercise price (in Dollars per share)

$ 0.2

Stock based compensation expenses (in Dollars)

$ 10,087

Ten-Year Options [Member]

Equity [Line Items]

Stock based compensation expenses (in Dollars)

24,635

$ 61,261

Mr. Garth [Member]

Equity [Line Items]

Warrant purchase price (in Dollars)

100,000

Mr. Garth [Member] | 2021 Equity Incentive Plan [Member]

Equity [Line Items]

Stock based compensation expenses (in Dollars)

1,594

Mr. Garth [Member] | Restricted Stock [Member] | 2021 Equity Incentive Plan [Member]

Equity [Line Items]

Common stock exercise price (in Dollars per share)

$ 0.22

Michael Feinsod [Member] | 2021 Equity Incentive Plan [Member]

Equity [Line Items]

Option to purchase share of common stock

333,333

Common stock exercise price (in Dollars per share)

$ 2.7

Premium over closing price, percentage

120%

Options were valued (in Dollars)

450,000

Hunter Garth [Member]

Equity [Line Items]

Stock based compensation expenses (in Dollars)

$ 12,318

$ 30,811

Hunter Garth [Member] | Equity Option [Member]

Equity [Line Items]

Option to purchase share of common stock

666,667

Common stock exercise price (in Dollars per share)

$ 2.7

Premium over closing price, percentage

120%

Series A Preferred Stock [Member]

Equity [Line Items]

Preferred stock, shares authorized

1,000

1,000

Preferred stock, shares issued

Preferred stock, shares outstanding

Series C Preferred Stock [Member]

Equity [Line Items]

Preferred stock, par value (in Dollars per share)

$ 0.001

$ 0.001

Preferred stock, shares issued

1

1

1

Preferred stock, shares outstanding

1

1

1

Preferred stock stated value (in Dollars)

$ 24,000

Voting power of percentage

51%

Equity (Details) - Schedule of

Equity (Details) - Schedule of Warrant Activities - Warrants [Member] - $ / shares		3 Months Ended
	Dec. 31, 2023	Mar. 31, 2024
Class of Warrant or Right [Line Items]
Number of Warrants, Outstanding balance (in Shares)	29,876	353,876
Weighted- Average Exercise Price Per Share, Outstanding balance	$ 25.24	$ 1
Weighted- Average Remaining Life, Outstanding balance	1 year 2 months 15 days	7 years 7 months 9 days
Number of Warrants, Exercisable (in Shares)		242,376
Weighted- Average Exercise Price Per Share, Exercisable		$ 1
Weighted- Average Remaining Life, Exercisable		7 years 7 months 9 days
Weighted- Average Exercise Price Per Share, Intrinsic value
Number of Warrants, Granted (in Shares)		324,000
Weighted- Average Exercise Price Per Share, Granted		$ 0.11
Weighted- Average Remaining Life, Granted		8 years 5 months 19 days
Number of Warrants, Canceled or expired (in Shares)
Weighted- Average Exercise Price Per Share, Canceled or expired
Weighted- Average Remaining Life, Canceled or expired

Equity (Details) - Schedule o_2

Equity (Details) - Schedule of Option Activities - Options [Member] - $ / shares		3 Months Ended
	Dec. 31, 2023	Mar. 31, 2024
Schedule of Option Activities [Line Items]
Number of Options, Outstanding, balance (in Shares)	1,246,341	1,345,341
Weighted- Average Exercise Price Per Share, Outstanding, balance	$ 2.67	$ 2.08
Weighted- Average Remaining Life, Outstanding, balance	7 years 11 months 8 days	7 years 1 month 9 days
Number of Options, Exercisable (in Shares)		690,508
Weighted- Average Exercise Price Per Share, Exercisable		$ 2.19
Weighted- Average Remaining Life, Exercisable		7 years 8 months 12 days
Weighted- Average Exercise Price Per Share, Intrinsic value
Number of Options, Granted (in Shares)		99,000
Weighted- Average Exercise Price Per Share, Granted		$ 0.22
Weighted- Average Remaining Life, Granted		4 years 10 months 17 days
Number of Options, Canceled or expired (in Shares)
Weighted- Average Exercise Price Per Share, Canceled or expired
Number of Options, Exercised (in Shares)
Weighted- Average Exercise Price Per Share, Exercised

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)					3 Months Ended	12 Months Ended
	Mar. 01, 2024	Aug. 17, 2023	Dec. 14, 2021	Dec. 13, 2021	Mar. 31, 2024	Dec. 31, 2023	Sep. 05, 2023
Related Party Transactions [Line Items]
Vesting period	5 years	5 years
Additional loan					$ 5,000	$ 487,372
Notes payable					849,500	849,500	$ 849,500
Percentage of interest bearing							5
Accrued salary					253,938
Accounts payable					156,944
Hunter Garth [Member]
Related Party Transactions [Line Items]
Salary			$ 8,000
Mr. Garth [Member]
Related Party Transactions [Line Items]
Purchase shares of common stock (in Shares)			333,333
Exercise price (in Dollars per share)			$ 2.7
Percentage of premium over the closing price of the common stock				120%
Mr. Garth [Member] | 2021 Equity Incentive Plan [Member]
Related Party Transactions [Line Items]
Vesting period			1 year
Note Payable [Member]
Related Party Transactions [Line Items]
Net proceeds					2,000,000		$ 2,000,000
Michael Feinsod [Member]
Related Party Transactions [Line Items]
Amount owed					$ 907,872	$ 902,872
Mr. Feinsod [Member]
Related Party Transactions [Line Items]
Purchase shares of common stock (in Shares)			666,667
Exercise price (in Dollars per share)			$ 2.7
Percentage of premium over the closing price of the common stock				120%
Mr. Feinsod [Member] | 2021 Equity Incentive Plan [Member]
Related Party Transactions [Line Items]
Vesting period			1 year
Shares of common stock (in Shares)			1,000,000
2021 Equity Incentive Plan [Member] | Mr. Garth [Member] | Restricted Stock [Member]
Related Party Transactions [Line Items]
Shares of common stock (in Shares)			500,000
2021 Equity Incentive Plan [Member] | Michael Feinsod [Member] | Restricted Stock [Member]
Related Party Transactions [Line Items]
Shares of common stock (in Shares)			10,000

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	Aug. 31, 2022	Aug. 11, 2022	Dec. 14, 2021	Dec. 13, 2021	Nov. 11, 2022	Oct. 28, 2021
Commitments and Contingencies [Line Items]
Original principal amount						$ 400,000
Operating profit, percentage	40%
Payment inventory					$ 90,000
Purchase of common stock			666,667
Premium, percentage				120%
Mr. Garth [Member]
Commitments and Contingencies [Line Items]
Salary			$ 8,000
Purchase of common stock			333,333
Mr. Feinsod [Member]
Commitments and Contingencies [Line Items]
Salary			$ 10,000
Osiris, LLC [Member]
Commitments and Contingencies [Line Items]
Common stock, shares issued		2,777,778
Equity Incentive Plan [Member] | Restricted Common Stock [Member]
Commitments and Contingencies [Line Items]
Exercise price			$ 2.7
Equity Incentive Plan [Member] | Mr. Garth [Member] | Restricted Common Stock [Member]
Commitments and Contingencies [Line Items]
Common stock			500,000
Equity Incentive Plan [Member] | Mr. Feinsod [Member]
Commitments and Contingencies [Line Items]
Exercise price			$ 0.06
Equity Incentive Plan [Member] | Mr. Feinsod [Member] | Restricted Common Stock [Member]
Commitments and Contingencies [Line Items]
Common stock			1,000,000
Common Stock [Member]
Commitments and Contingencies [Line Items]
Premium, percentage				120%
Inventory Earn Out [Member]
Commitments and Contingencies [Line Items]
Final payment of inventory earn out	$ 75,000

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)			3 Months Ended
	Jun. 06, 2024	May 20, 2024	Mar. 31, 2024
Subsequent Events [Line Items]
Loaned			$ 16,000
Forecast [Member]
Subsequent Events [Line Items]
Senior secured notes	$ 25,000	$ 10,000
Percentage of senior secured notes	15%	15%
Warrants to purchase (in Shares)	25,000	10,000
Aggregate purchase price	$ 25,000	$ 10,000
Exercise price per share (in Dollars per share)	$ 0.11	$ 0.11